Cutaneous Oncology News

A facial moisturizer that contains sunscreen did not leave a white cast on individuals with skin of color, providing a formulation that will encourage sun protection, according to a study.

New interim results showed that HyBryte treatment demonstrated positive outcomes in patients with early-stage cutaneous T-cell lymphoma, according to a Soligenix press release.

About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.

Patients with rosacea have an increased risk for malignant melanoma, joint problems, metabolic disease and visual disturbances, according to a study.

Healio has compiled June’s most-read news in dermatology.

Iovance Biotherapeutics has submitted a marketing authorization application to the European Medicines Agency for lifileucel to treat advanced melanoma, the company announced in a press release.

Rural populations, especially those with skin of color, experience higher prevalence and an increased risk for skin cancer, according to a study.

IceCure Medical has received marketing authorization from the FDA for its next-generation single probe cryoablation system, the company announced in a press release.

Prior radiotherapy was associated with progression-free survival in patients with metastatic cutaneous squamous cell carcinoma treated with cemiplimab, according to a study.

Individuals with skin of color experience barriers to sunscreen usage, warranting dermatologists and other health care providers to address these challenges, according to a study.